Saratoga Investment Corp (NYSE:SAR) announced financial results for the fiscal third quarter ended November 30, 2010. For the quarter ended November 30, 2010, Saratoga Investment Corp. reported net investment income of $1.9 million, or $0.70 per share, and net gain on investments of $1.4 million, or $0.50 per share, resulting in a net increase in net assets from operations of $3.3 million, or $1.20 per share. Net asset value was $24.95 per share as of November 30, 2010 as compared to $29.71 per share reported as of August 31, 2010.
Saratoga Investment Corp is a private equity firm specializing in buyout, acquisition, growth, recapitalization, and note financing transactions of private middle market companies and select high yield bonds.
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.
Alzheimer's gets worse over time. Alzheimer's disease is a developing condition, at which symptoms slowly intensify over a period of time. Continuing, memory loss is mild, however with late-stage Alzheimer's disease, people lose the ability to hold on a dialogue as well as react to their surroundings. Alzheimer's is the 6th main source of death in the united states. People with Alzheimer's are living an average of eight years following an individual's symptoms developing into being recognizable to many others, but yet survival may range from three to 20 years, based upon years of age and various medical ailments.
Cancer of the breast is a form of cancer in which cells in the breast split and also grow without control. About 85 % of breast cancers begin in the particular mammary ducts, though about 15 per cent happen in the lobules. Tumors within the breasts tend to grow slowly. As soon as a mass is actually big enough in order to feel, it may are already thriving for as long as a decade. However, many growths may be severe, and therefore increase far more rapidly.
Parkinson’s disease is really a problem that affects nerve cells, or neurons, inside of a section of the brain of which controls muscle motions. In Parkinson’s, nerves which make an important chemical called dopamine die or do not work properly. Dopamine generally delivers impulses that assist synchronize a person’s activities.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials.
Majestic Gold Corp. (TSX.V:MJS) (FSE:MJT) is a Vancouver-based; TSX Venture Exchange and Frankfurt Exchange listed gold exploration and development company with a very advanced gold deposit in Shandong province of China.
The Song Jiaguo Property is located on the Jiaodong Peninsula in Muping County, the Shandong Province, the People’s Republic of China.
The property lies on the western edge of the Muping-Fushan Gold Belt, which hosts 20% of the known gold deposits on the Jiaodong Peninsula.
Majestic Gold Corp. is pleased to announce that Wardrop, A Tetra Tech Company, (”Wardrop”) has completed and delivered a positive Preliminary Assessment (”PA” or “Preliminary Assessment”) for the Songjiagou Gold Project located in Shandong Province, People’s Republic of China.
“The Preliminary Assessment provided by Wardrop has exceeded our expectations and will form the basis for our continued development of the Songjiagou project,” stated Rod Husband, President and CEO of Majestic Gold Corp.
For More Information On Majestic Gold: www.majesticgold.net
John Hancock Investors Trust (NYSE:JHI) announced that Steven R. Pruchansky, an independent Trustee of the John Hancock Funds, has been appointed Chair of the Boards of Trustees effective January 1, 2011. Mr. Pruchansky succeeds Patti McGill Peterson, an independent Trustee who served as Chair for a two-year term from January 1, 2009 until December 31, 2010. Mr. Pruchansky has served as an independent Trustee of various John Hancock Funds since 1992. Mr. Pruchansky is also the Chairman and Chief Executive Officer of Greenscapes of Southwest Florida, Inc. (since 2000). In addition, he is a Member of Board of Advisors of First American Bank (since 2008) and a Managing Director of Jon James, LLC (since 2000).
John Hancock Financial is a unit of Manulife Financial Corporation, a leading Canadian-based financial services group serving millions of customers in 22 countries and territories worldwide.
Tyler Technologies, Inc. (NYSE:TYL) announced it has reached an agreement with Columbus City Schools in Ohio to provide its Munis® enterprise resource planning (ERP) solution, part of Tyler’s complete school solution. Columbus City Schools, Ohio’s largest school district with more than 50,000 students, has invested in an extensive range of Tyler’s Munis financial, human capital management and document management applications. In addition to software licenses, the agreement includes related professional services, maintenance and support.
Tyler Technologies, Inc. provides integrated information management solutions and services for local governments in the United States, Canada, Puerto Rico, and the United Kingdom.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.
Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty-five thousand dollars in cash from Majestic Gold Corp. (TSX Venture Exchange (TSX.V:MJS) and the Frankfurt Stock Exchange (FSE:MJT)) for 30 (thirty) days of advertising, as well as for assistance in becoming a fully reporting publicly trading Bulletin Board company.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.